-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Reiterates Overweight on Omada Health, Maintains $30 Price Target

Benzinga·06/22/2026 17:51:02
Listen to the news
Morgan Stanley analyst Craig Hettenbach reiterates Omada Health (NASDAQ:OMDA) with a Overweight and maintains $30 price target.